Check the label for directions before use. Shake the inhaler. While you are breathing in from mouth, press down on the inhaler one time to release the medication and hold your breath for 10 seconds. Repeat until you have inhaled the number of puffs as suggested by the doctor.Afterwards, rinse your mouth thoroughly with water and spit it out.
Salbair B 100mcg/50mcg Inhaler is a combination of two medicines: Salbutamol / Albuterol and Beclometasone. Salbutamol / Albuterol is a bronchodilator which works by relaxing the muscles in the airways and widens the airways. Beclometasone is a steroid. It acts by stopping the release of certain natural substances in body that are responsible for inflammation (swelling) of the airways. Together, they make breathing easier.
Salbair B 100mcg/50mcg Inhaler may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Salbair B 100mcg/50mcg Inhaler is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well. Salbair B 100mcg/50mcg Inhaler may cause side effects such as dizziness, increased or uneven heart rate, muscle cramps or muscle pain. This may affect your ability to drive.
There is limited information available on the use of Salbair B 100mcg/50mcg Inhaler in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Salbair B 100mcg/50mcg Inhaler in patients with liver disease. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Salbair B 100mcg/50mcg Inhaler. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.